Corticosteroids are used frequently and quite liberally in the treatment of many diseases and disorders in respiratory medicine. They provide therapeutic benefits when indications are appropriate. However, they may also lead to many complications and adverse effects causing significant safety issues for patients when the dose and treatment duration are exaggerated and overlooked, or when appropriate indications are not exercised.
In the pertinent literature, there are no guidelines, standardization, or consensus on how to use corticosteroids safely in respiratory medicine. Thus, there is a gap in showing the exact magnitude of complications of corticosteroids in different areas of respiratory medicine.
This Research Topic aims to demonstrate the safety of corticosteroids in various areas of respiratory medicine through a meticulous literature search for the issues related to safety (complications, adverse effects, dose, duration, and other details) concerning indications and benefits. The causes and predisposing factors for complications will also be revealed.
Furthermore, this Research Topic will contribute significantly to the rational use of corticosteroids by increasing the level of vigilance for complications and factors leading to complications. Consequently, preventive measures and limitations in dose and duration of use will be exercised more carefully. Ultimately, the safety of corticosteroids will be improved in respiratory diseases and procedures.
This article collection will focus on the safety of corticosteroids in the various diseases, disorders, and procedures in respiratory medicine: Lung Cancer and Other Malignant Diseases, Chronic Obstructive Lung Disease, Asthma, and Allergic Diseases, Bronchiectasis, Interstitial Diseases, and Collagen Vascular Diseases, Tuberculosis and Nontuberculous Mycobacterial Infections, Nontuberculous Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections, Pleural and Mediastinal Disorders, and Conventional Procedures and Interventional Pulmonology.
Each theme mentioned above will focus on the safety issues and their causes and predisposing factors with respect to indications and benefits by reviewing the evidence-based pertinent literature and will conclude with key points and recommendations regarding safety in the use of corticosteroids.
Corticosteroids are used frequently and quite liberally in the treatment of many diseases and disorders in respiratory medicine. They provide therapeutic benefits when indications are appropriate. However, they may also lead to many complications and adverse effects causing significant safety issues for patients when the dose and treatment duration are exaggerated and overlooked, or when appropriate indications are not exercised.
In the pertinent literature, there are no guidelines, standardization, or consensus on how to use corticosteroids safely in respiratory medicine. Thus, there is a gap in showing the exact magnitude of complications of corticosteroids in different areas of respiratory medicine.
This Research Topic aims to demonstrate the safety of corticosteroids in various areas of respiratory medicine through a meticulous literature search for the issues related to safety (complications, adverse effects, dose, duration, and other details) concerning indications and benefits. The causes and predisposing factors for complications will also be revealed.
Furthermore, this Research Topic will contribute significantly to the rational use of corticosteroids by increasing the level of vigilance for complications and factors leading to complications. Consequently, preventive measures and limitations in dose and duration of use will be exercised more carefully. Ultimately, the safety of corticosteroids will be improved in respiratory diseases and procedures.
This article collection will focus on the safety of corticosteroids in the various diseases, disorders, and procedures in respiratory medicine: Lung Cancer and Other Malignant Diseases, Chronic Obstructive Lung Disease, Asthma, and Allergic Diseases, Bronchiectasis, Interstitial Diseases, and Collagen Vascular Diseases, Tuberculosis and Nontuberculous Mycobacterial Infections, Nontuberculous Bacterial Infections, Viral Infections, Fungal Infections, Parasitic Infections, Pleural and Mediastinal Disorders, and Conventional Procedures and Interventional Pulmonology.
Each theme mentioned above will focus on the safety issues and their causes and predisposing factors with respect to indications and benefits by reviewing the evidence-based pertinent literature and will conclude with key points and recommendations regarding safety in the use of corticosteroids.